> top > docs > PubMed:23514715 > annotations
TextAE configuration unavailable!

PubMed:23514715 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 112-123 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T2 1371-1382 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 112-123 Glycan_Motif denotes chondroitin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT
T2 1371-1382 Glycan_Motif denotes chondroitin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-74 Sentence denotes Glycosaminoglycans in the blood of hereditary multiple exostoses patients:
TextSentencer_T2 75-178 Sentence denotes Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application.
TextSentencer_T3 179-511 Sentence denotes Hereditary multiple exostoses (HME) is an autosomal dominant skeletal disorder with wide variation in clinical phenotype and is caused by heterogeneous germline mutations in two of the Ext genes, EXT-1 and EXT-2, which encode ubiquitously expressed glycosyltransferases involved in the polymerization of heparan sulfate (HS) chains.
TextSentencer_T4 512-812 Sentence denotes To examine whether the Ext mutation could affect HS structures and amounts in HME patients being heterozygous for the Ext genes, we collected blood from patients and healthy individuals, separated it into plasma and cellular fractions and then isolated glycosaminoglycans (GAGs) from those fractions.
TextSentencer_T5 813-1186 Sentence denotes A newly established method consisting of a combination of selective ethanol precipitation of GAGs, digestion of GAGs recovered on the filter-cup by direct addition of heparitinase or chondroitinase reaction solution and subsequent high-performance liquid chromatography of the unsaturated disaccharide products enabled the analysis using the least amount of blood (200 µL).
TextSentencer_T6 1187-1310 Sentence denotes We found that HS structures of HME patients were almost similar to those of controls in both plasma and cellular fractions.
TextSentencer_T7 1311-1645 Sentence denotes However, interestingly, although both the amounts of HS and chondroitin sulfate (CS) varied depending on the different individuals, the amounts of HS in both the plasma and cellular fractions of HME patient samples were decreased and the ratios of HS to CS (HS/CS) of HME patient samples were almost half those of healthy individuals.
TextSentencer_T8 1646-1792 Sentence denotes The results suggest that HME patients' blood exhibited reduced HS amounts and HS/CS ratios, which could be used as a diagnostic biomarker for HME.
T1 0-74 Sentence denotes Glycosaminoglycans in the blood of hereditary multiple exostoses patients:
T2 75-178 Sentence denotes Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application.
T3 179-511 Sentence denotes Hereditary multiple exostoses (HME) is an autosomal dominant skeletal disorder with wide variation in clinical phenotype and is caused by heterogeneous germline mutations in two of the Ext genes, EXT-1 and EXT-2, which encode ubiquitously expressed glycosyltransferases involved in the polymerization of heparan sulfate (HS) chains.
T4 512-812 Sentence denotes To examine whether the Ext mutation could affect HS structures and amounts in HME patients being heterozygous for the Ext genes, we collected blood from patients and healthy individuals, separated it into plasma and cellular fractions and then isolated glycosaminoglycans (GAGs) from those fractions.
T5 813-1186 Sentence denotes A newly established method consisting of a combination of selective ethanol precipitation of GAGs, digestion of GAGs recovered on the filter-cup by direct addition of heparitinase or chondroitinase reaction solution and subsequent high-performance liquid chromatography of the unsaturated disaccharide products enabled the analysis using the least amount of blood (200 µL).
T6 1187-1310 Sentence denotes We found that HS structures of HME patients were almost similar to those of controls in both plasma and cellular fractions.
T7 1311-1645 Sentence denotes However, interestingly, although both the amounts of HS and chondroitin sulfate (CS) varied depending on the different individuals, the amounts of HS in both the plasma and cellular fractions of HME patient samples were decreased and the ratios of HS to CS (HS/CS) of HME patient samples were almost half those of healthy individuals.
T8 1646-1792 Sentence denotes The results suggest that HME patients' blood exhibited reduced HS amounts and HS/CS ratios, which could be used as a diagnostic biomarker for HME.
T1 0-74 Sentence denotes Glycosaminoglycans in the blood of hereditary multiple exostoses patients:
T2 75-178 Sentence denotes Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application.
T3 179-511 Sentence denotes Hereditary multiple exostoses (HME) is an autosomal dominant skeletal disorder with wide variation in clinical phenotype and is caused by heterogeneous germline mutations in two of the Ext genes, EXT-1 and EXT-2, which encode ubiquitously expressed glycosyltransferases involved in the polymerization of heparan sulfate (HS) chains.
T4 512-812 Sentence denotes To examine whether the Ext mutation could affect HS structures and amounts in HME patients being heterozygous for the Ext genes, we collected blood from patients and healthy individuals, separated it into plasma and cellular fractions and then isolated glycosaminoglycans (GAGs) from those fractions.
T5 813-1186 Sentence denotes A newly established method consisting of a combination of selective ethanol precipitation of GAGs, digestion of GAGs recovered on the filter-cup by direct addition of heparitinase or chondroitinase reaction solution and subsequent high-performance liquid chromatography of the unsaturated disaccharide products enabled the analysis using the least amount of blood (200 µL).
T6 1187-1310 Sentence denotes We found that HS structures of HME patients were almost similar to those of controls in both plasma and cellular fractions.
T7 1311-1645 Sentence denotes However, interestingly, although both the amounts of HS and chondroitin sulfate (CS) varied depending on the different individuals, the amounts of HS in both the plasma and cellular fractions of HME patient samples were decreased and the ratios of HS to CS (HS/CS) of HME patient samples were almost half those of healthy individuals.
T8 1646-1792 Sentence denotes The results suggest that HME patients' blood exhibited reduced HS amounts and HS/CS ratios, which could be used as a diagnostic biomarker for HME.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 112-123 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T2 1371-1382 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 93-108 http://www.glycoepitope.jp/epitopes/EP0086 denotes heparan sulfate
T2 112-123 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
T3 483-498 http://www.glycoepitope.jp/epitopes/EP0086 denotes heparan sulfate
T4 500-502 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T5 561-563 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T6 1201-1203 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T7 1364-1366 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T8 1371-1382 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
T9 1458-1460 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T10 1559-1561 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T11 1569-1571 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T12 1709-1711 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS
T13 1724-1726 http://www.glycoepitope.jp/epitopes/EP0086 denotes HS

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 26-31 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T2 26-31 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T3 654-659 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T4 654-659 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T5 1171-1176 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T6 1171-1176 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T7 1685-1690 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T8 1685-1690 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood

DisGeNET

Id Subject Object Predicate Lexical cue
T0 364-367 gene:2131 denotes Ext
T1 179-208 disease:C0015306 denotes Hereditary multiple exostoses
T2 364-367 gene:2131 denotes Ext
T3 210-213 disease:C0015306 denotes HME
T4 364-367 gene:2131 denotes Ext
T5 240-257 disease:C0263661 denotes skeletal disorder
T6 375-380 gene:2131 denotes EXT-1
T7 179-208 disease:C0015306 denotes Hereditary multiple exostoses
T8 375-380 gene:2131 denotes EXT-1
T9 210-213 disease:C0015306 denotes HME
T10 375-380 gene:2131 denotes EXT-1
T11 240-257 disease:C0263661 denotes skeletal disorder
T12 385-390 gene:2132 denotes EXT-2
T13 179-208 disease:C0015306 denotes Hereditary multiple exostoses
T14 385-390 gene:2133 denotes EXT-2
T15 179-208 disease:C0015306 denotes Hereditary multiple exostoses
T16 385-390 gene:2132 denotes EXT-2
T17 210-213 disease:C0015306 denotes HME
T18 385-390 gene:2133 denotes EXT-2
T19 210-213 disease:C0015306 denotes HME
T20 385-390 gene:2132 denotes EXT-2
T21 240-257 disease:C0263661 denotes skeletal disorder
T22 385-390 gene:2133 denotes EXT-2
T23 240-257 disease:C0263661 denotes skeletal disorder
R1 T0 T1 associated_with Ext,Hereditary multiple exostoses
R2 T2 T3 associated_with Ext,HME
R3 T4 T5 associated_with Ext,skeletal disorder
R4 T6 T7 associated_with EXT-1,Hereditary multiple exostoses
R5 T8 T9 associated_with EXT-1,HME
R6 T10 T11 associated_with EXT-1,skeletal disorder
R7 T12 T13 associated_with EXT-2,Hereditary multiple exostoses
R8 T14 T15 associated_with EXT-2,Hereditary multiple exostoses
R9 T16 T17 associated_with EXT-2,HME
R10 T18 T19 associated_with EXT-2,HME
R11 T20 T21 associated_with EXT-2,skeletal disorder
R12 T22 T23 associated_with EXT-2,skeletal disorder

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 0-18 FMAID:167395 denotes Glycosaminoglycans
_T2 0-18 FMAID:63011 denotes Glycosaminoglycans
_T3 26-31 FMAID:256053 denotes blood
_T4 93-100 FMAID:165191 denotes heparan
_T5 93-100 FMAID:67110 denotes heparan
_T6 93-108 FMAID:167405 denotes heparan sulfate
_T7 93-108 FMAID:63023 denotes heparan sulfate
_T8 112-131 FMAID:196838 denotes chondroitin sulfate
_T9 112-131 FMAID:82837 denotes chondroitin sulfate
_T10 221-230 FMAID:74406 denotes autosomal
_T11 221-230 FMAID:176862 denotes autosomal
_T12 368-373 FMAID:198663 denotes genes
_T13 483-490 FMAID:67110 denotes heparan
_T14 483-490 FMAID:165191 denotes heparan
_T15 483-498 FMAID:63023 denotes heparan sulfate
_T16 483-498 FMAID:167405 denotes heparan sulfate
_T17 634-639 FMAID:198663 denotes genes
_T18 654-659 FMAID:256053 denotes blood
_T19 717-723 FMAID:162307 denotes plasma
_T20 765-783 FMAID:167395 denotes glycosaminoglycans
_T21 765-783 FMAID:63011 denotes glycosaminoglycans
_T22 785-789 FMAID:167404 denotes GAGs
_T23 906-910 FMAID:167404 denotes GAGs
_T24 925-929 FMAID:167404 denotes GAGs
_T25 1061-1067 FMAID:85815 denotes liquid
_T26 1102-1114 FMAID:196733 denotes disaccharide
_T27 1102-1114 FMAID:82744 denotes disaccharide
_T28 1171-1176 FMAID:256053 denotes blood
_T29 1280-1286 FMAID:162307 denotes plasma
_T30 1371-1390 FMAID:82837 denotes chondroitin sulfate
_T31 1371-1390 FMAID:196838 denotes chondroitin sulfate
_T32 1473-1479 FMAID:162307 denotes plasma
_T33 1685-1690 FMAID:256053 denotes blood

uniprot-human

Id Subject Object Predicate Lexical cue
T1 210-213 http://www.uniprot.org/uniprot/P39900 denotes HME
T2 590-593 http://www.uniprot.org/uniprot/P39900 denotes HME
T3 1218-1221 http://www.uniprot.org/uniprot/P39900 denotes HME
T4 1506-1509 http://www.uniprot.org/uniprot/P39900 denotes HME
T5 1579-1582 http://www.uniprot.org/uniprot/P39900 denotes HME
T6 1671-1674 http://www.uniprot.org/uniprot/P39900 denotes HME
T7 1788-1791 http://www.uniprot.org/uniprot/P39900 denotes HME
T8 996-1010 http://www.uniprot.org/uniprot/P34059 denotes chondroitinase
T9 1392-1394 http://www.uniprot.org/uniprot/O75390 denotes CS
T10 1565-1567 http://www.uniprot.org/uniprot/O75390 denotes CS
T11 1572-1574 http://www.uniprot.org/uniprot/O75390 denotes CS
T12 1727-1729 http://www.uniprot.org/uniprot/O75390 denotes CS

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 996-1010 http://www.uniprot.org/uniprot/Q571E4 denotes chondroitinase

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 221-230 http://purl.bioontology.org/ontology/NCBITAXON/150701 denotes autosomal
T2 317-330 http://purl.bioontology.org/ontology/NCBITAXON/1113441 denotes heterogeneous
T3 317-330 http://purl.bioontology.org/ontology/NCBITAXON/691256 denotes heterogeneous
T4 609-621 http://purl.bioontology.org/ontology/NCBITAXON/1369269 denotes heterozygous

GO-BP

Id Subject Object Predicate Lexical cue
T1 101-108 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T2 124-131 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T3 491-498 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T4 1383-1390 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T5 728-736 http://purl.obolibrary.org/obo/GO_0007349 denotes cellular
T6 1291-1299 http://purl.obolibrary.org/obo/GO_0007349 denotes cellular
T7 1484-1492 http://purl.obolibrary.org/obo/GO_0007349 denotes cellular
T8 912-921 http://purl.obolibrary.org/obo/GO_0007586 denotes digestion
T9 996-1010 http://purl.obolibrary.org/obo/GO_0043890 denotes chondroitinase

GO-CC

Id Subject Object Predicate Lexical cue
T1 221-230 http://purl.obolibrary.org/obo/GO_0030849 denotes autosomal

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 26-31 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T2 654-659 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T3 1171-1176 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T4 1685-1690 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

EDAM-topics

Id Subject Object Predicate Lexical cue
T1 290-299 http://edamontology.org/topic_0625 denotes phenotype
T2 340-349 http://edamontology.org/topic_0199 denotes mutations
T3 539-547 http://edamontology.org/topic_0199 denotes mutation
T4 1518-1525 http://edamontology.org/topic_3277 denotes samples
T5 1591-1598 http://edamontology.org/topic_3277 denotes samples
T6 1774-1783 http://edamontology.org/topic_3360 denotes biomarker

EDAM-DFO

Id Subject Object Predicate Lexical cue
T1 290-299 http://edamontology.org/data_3275 denotes phenotype
T2 564-574 http://edamontology.org/data_0883 denotes structures
T3 947-953 http://edamontology.org/operation_3695 denotes filter
T4 1136-1144 http://edamontology.org/operation_2945 denotes analysis
T5 1204-1214 http://edamontology.org/data_0883 denotes structures

Allie

Id Subject Object Predicate Lexical cue
SS1_23514715_1_0 179-208 expanded denotes Hereditary multiple exostoses
SS2_23514715_1_0 210-213 abbr denotes HME
SS1_23514715_1_1 483-498 expanded denotes heparan sulfate
SS2_23514715_1_1 500-502 abbr denotes HS
SS1_23514715_2_0 765-783 expanded denotes glycosaminoglycans
SS2_23514715_2_0 785-789 abbr denotes GAGs
SS1_23514715_5_0 1371-1390 expanded denotes chondroitin sulfate
SS2_23514715_5_0 1392-1394 abbr denotes CS
SS1_23514715_5_1 1559-1567 expanded denotes HS to CS
SS2_23514715_5_1 1569-1574 abbr denotes HS/CS
AE1_23514715_1_0 SS1_23514715_1_0 SS2_23514715_1_0 abbreviatedTo Hereditary multiple exostoses,HME
AE1_23514715_1_1 SS1_23514715_1_1 SS2_23514715_1_1 abbreviatedTo heparan sulfate,HS
AE1_23514715_2_0 SS1_23514715_2_0 SS2_23514715_2_0 abbreviatedTo glycosaminoglycans,GAGs
AE1_23514715_5_0 SS1_23514715_5_0 SS2_23514715_5_0 abbreviatedTo chondroitin sulfate,CS
AE1_23514715_5_1 SS1_23514715_5_1 SS2_23514715_5_1 abbreviatedTo HS to CS,HS/CS

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 190-208 HP_0002762 denotes multiple exostoses
T2 199-208 HP_0100777 denotes exostoses
T3 221-239 HP_0000006 denotes autosomal dominant
T4 240-257 HP_0000924 denotes skeletal disorder

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
23514715-1#206#211#gene2132 385-390 gene2132 denotes EXT-2
23514715-1#206#211#gene2133 385-390 gene2133 denotes EXT-2
23514715-1#206#211#gene2132 385-390 gene2132 denotes EXT-2
23514715-1#206#211#gene2133 385-390 gene2133 denotes EXT-2
23514715-1#206#211#gene2132 385-390 gene2132 denotes EXT-2
23514715-1#206#211#gene2133 385-390 gene2133 denotes EXT-2
23514715-1#185#188#gene2131 364-367 gene2131 denotes Ext
23514715-1#196#201#gene2131 375-380 gene2131 denotes EXT-1
23514715-1#0#29#diseaseC0015306 179-208 diseaseC0015306 denotes Hereditary multiple exostoses
23514715-1#31#34#diseaseC0015306 210-213 diseaseC0015306 denotes HME
23514715-1#61#78#diseaseC0263661 240-257 diseaseC0263661 denotes skeletal disorder
23514715-1#0#29#diseaseC0015306 179-208 diseaseC0015306 denotes Hereditary multiple exostoses
23514715-1#31#34#diseaseC0015306 210-213 diseaseC0015306 denotes HME
23514715-1#61#78#diseaseC0263661 240-257 diseaseC0263661 denotes skeletal disorder
23514715-1#0#29#diseaseC0015306 179-208 diseaseC0015306 denotes Hereditary multiple exostoses
23514715-1#31#34#diseaseC0015306 210-213 diseaseC0015306 denotes HME
23514715-1#61#78#diseaseC0263661 240-257 diseaseC0263661 denotes skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21320#29#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213231#34#diseaseC0015306 23514715-1#206#211#gene2132 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213261#78#diseaseC0263661 23514715-1#206#211#gene2132 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
206#211#gene21330#29#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#0#29#diseaseC0015306 associated_with EXT-2,Hereditary multiple exostoses
206#211#gene213331#34#diseaseC0015306 23514715-1#206#211#gene2133 23514715-1#31#34#diseaseC0015306 associated_with EXT-2,HME
206#211#gene213361#78#diseaseC0263661 23514715-1#206#211#gene2133 23514715-1#61#78#diseaseC0263661 associated_with EXT-2,skeletal disorder
185#188#gene21310#29#diseaseC0015306 23514715-1#185#188#gene2131 23514715-1#0#29#diseaseC0015306 associated_with Ext,Hereditary multiple exostoses
185#188#gene213131#34#diseaseC0015306 23514715-1#185#188#gene2131 23514715-1#31#34#diseaseC0015306 associated_with Ext,HME
185#188#gene213161#78#diseaseC0263661 23514715-1#185#188#gene2131 23514715-1#61#78#diseaseC0263661 associated_with Ext,skeletal disorder
185#188#gene21310#29#diseaseC0015306 23514715-1#185#188#gene2131 23514715-1#0#29#diseaseC0015306 associated_with Ext,Hereditary multiple exostoses
185#188#gene213131#34#diseaseC0015306 23514715-1#185#188#gene2131 23514715-1#31#34#diseaseC0015306 associated_with Ext,HME
185#188#gene213161#78#diseaseC0263661 23514715-1#185#188#gene2131 23514715-1#61#78#diseaseC0263661 associated_with Ext,skeletal disorder
185#188#gene21310#29#diseaseC0015306 23514715-1#185#188#gene2131 23514715-1#0#29#diseaseC0015306 associated_with Ext,Hereditary multiple exostoses
185#188#gene213131#34#diseaseC0015306 23514715-1#185#188#gene2131 23514715-1#31#34#diseaseC0015306 associated_with Ext,HME
185#188#gene213161#78#diseaseC0263661 23514715-1#185#188#gene2131 23514715-1#61#78#diseaseC0263661 associated_with Ext,skeletal disorder
196#201#gene21310#29#diseaseC0015306 23514715-1#196#201#gene2131 23514715-1#0#29#diseaseC0015306 associated_with EXT-1,Hereditary multiple exostoses
196#201#gene213131#34#diseaseC0015306 23514715-1#196#201#gene2131 23514715-1#31#34#diseaseC0015306 associated_with EXT-1,HME
196#201#gene213161#78#diseaseC0263661 23514715-1#196#201#gene2131 23514715-1#61#78#diseaseC0263661 associated_with EXT-1,skeletal disorder
196#201#gene21310#29#diseaseC0015306 23514715-1#196#201#gene2131 23514715-1#0#29#diseaseC0015306 associated_with EXT-1,Hereditary multiple exostoses
196#201#gene213131#34#diseaseC0015306 23514715-1#196#201#gene2131 23514715-1#31#34#diseaseC0015306 associated_with EXT-1,HME
196#201#gene213161#78#diseaseC0263661 23514715-1#196#201#gene2131 23514715-1#61#78#diseaseC0263661 associated_with EXT-1,skeletal disorder
196#201#gene21310#29#diseaseC0015306 23514715-1#196#201#gene2131 23514715-1#0#29#diseaseC0015306 associated_with EXT-1,Hereditary multiple exostoses
196#201#gene213131#34#diseaseC0015306 23514715-1#196#201#gene2131 23514715-1#31#34#diseaseC0015306 associated_with EXT-1,HME
196#201#gene213161#78#diseaseC0263661 23514715-1#196#201#gene2131 23514715-1#61#78#diseaseC0263661 associated_with EXT-1,skeletal disorder

GlycoBiology-MAT

Id Subject Object Predicate Lexical cue
T1 26-31 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T2 26-31 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T3 654-659 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T4 654-659 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T5 1171-1176 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T6 1171-1176 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T7 1685-1690 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood
T8 1685-1690 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood

GlycoBiology-Motifs

Id Subject Object Predicate Lexical cue
T1 112-123 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin
T2 1371-1382 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin
T3 112-131 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin sulfate
T4 1371-1390 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin sulfate

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 112-123 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
PD-GlycoEpitope-B_T2 1371-1382 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
PD-GlycoEpitope-B_T3 93-108 http://www.glycoepitope.jp/epitopes/EP0086 denotes heparan sulfate
PD-GlycoEpitope-B_T4 483-498 http://www.glycoepitope.jp/epitopes/EP0086 denotes heparan sulfate

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 26-31 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
PD-UBERON-AE-B_T2 654-659 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
PD-UBERON-AE-B_T3 1171-1176 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
PD-UBERON-AE-B_T4 1685-1690 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 112-123 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T2 1371-1382 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T3 93-108 Glycan denotes heparan sulfate https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T5 483-498 Glycan denotes heparan sulfate https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T6 500-502 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T7 561-563 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T8 1201-1203 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T9 1364-1366 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T11 1458-1460 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T12 1559-1561 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T13 1569-1571 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T14 1709-1711 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T15 1724-1726 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 26-31 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315
T3 654-659 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315
T5 1171-1176 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315
T7 1685-1690 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 46-64 Phenotype denotes multiple exostoses HP:0002762
T2 190-208 Phenotype denotes multiple exostoses HP:0002762

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 35-64 Disease denotes hereditary multiple exostoses http://purl.obolibrary.org/obo/MONDO_0005508
T2 190-208 Disease denotes multiple exostoses http://purl.obolibrary.org/obo/MONDO_0005508
T3 210-213 Disease denotes HME http://purl.obolibrary.org/obo/MONDO_0000225|http://purl.obolibrary.org/obo/MONDO_0005508
T5 590-593 Disease denotes HME http://purl.obolibrary.org/obo/MONDO_0000225|http://purl.obolibrary.org/obo/MONDO_0005508
T7 1218-1221 Disease denotes HME http://purl.obolibrary.org/obo/MONDO_0000225|http://purl.obolibrary.org/obo/MONDO_0005508
T9 1506-1509 Disease denotes HME http://purl.obolibrary.org/obo/MONDO_0000225|http://purl.obolibrary.org/obo/MONDO_0005508
T11 1579-1582 Disease denotes HME http://purl.obolibrary.org/obo/MONDO_0000225|http://purl.obolibrary.org/obo/MONDO_0005508
T13 1671-1674 Disease denotes HME http://purl.obolibrary.org/obo/MONDO_0000225|http://purl.obolibrary.org/obo/MONDO_0005508
T15 1788-1791 Disease denotes HME http://purl.obolibrary.org/obo/MONDO_0000225|http://purl.obolibrary.org/obo/MONDO_0005508

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 112-123 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T2 1371-1382 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T7 93-108 Glycan denotes heparan sulfate https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T3 483-498 Glycan denotes heparan sulfate https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T4 500-502 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T5 561-563 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T6 1201-1203 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T9 1364-1366 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T11 1458-1460 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T12 1559-1561 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T13 1569-1571 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T14 1709-1711 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW
T15 1724-1726 Glycan denotes HS https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 93-108 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes heparan sulfate http://www.glycoepitope.jp/epitopes/EP0086
T2 112-123 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T3 483-498 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes heparan sulfate http://www.glycoepitope.jp/epitopes/EP0086
T4 500-502 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T5 561-563 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T6 1201-1203 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T7 1364-1366 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T8 1371-1382 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T9 1458-1460 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T10 1559-1561 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T11 1569-1571 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T12 1709-1711 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T13 1724-1726 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 46-64 Phenotype denotes multiple exostoses HP:0002762
T2 190-208 Phenotype denotes multiple exostoses HP:0002762

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 26-31 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T2 654-659 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T3 717-723 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T4 1171-1176 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T5 1280-1286 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T6 1473-1479 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T7 1685-1690 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 35-64 Disease denotes hereditary multiple exostoses MONDO:0005508
T2 190-208 Disease denotes multiple exostoses MONDO:0005508
T3 210-213 Disease denotes HME MONDO:0005508
T4 590-593 Disease denotes HME MONDO:0005508
T5 1218-1221 Disease denotes HME MONDO:0005508
T6 1506-1509 Disease denotes HME MONDO:0005508
T7 1579-1582 Disease denotes HME MONDO:0005508
T8 1671-1674 Disease denotes HME MONDO:0005508
T9 1788-1791 Disease denotes HME MONDO:0005508

GlyCosmos15-Taxon

Id Subject Object Predicate Lexical cue db_id
T1 65-73 Organism denotes patients 9606
T2 594-602 Organism denotes patients 9606
T3 665-673 Organism denotes patients 9606
T4 1222-1230 Organism denotes patients 9606
T5 1510-1517 Organism denotes patient 9606
T6 1583-1590 Organism denotes patient 9606
T7 1675-1683 Organism denotes patients 9606

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 93-108 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes heparan sulfate http://www.glycoepitope.jp/epitopes/EP0086
T2 112-123 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T3 483-498 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes heparan sulfate http://www.glycoepitope.jp/epitopes/EP0086
T4 500-502 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T5 561-563 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T6 1201-1203 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T7 1364-1366 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T8 1371-1382 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T9 1458-1460 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T10 1559-1561 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T11 1569-1571 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T12 1709-1711 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T13 1724-1726 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-74 Sentence denotes Glycosaminoglycans in the blood of hereditary multiple exostoses patients:
T2 75-178 Sentence denotes Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application.
T3 179-511 Sentence denotes Hereditary multiple exostoses (HME) is an autosomal dominant skeletal disorder with wide variation in clinical phenotype and is caused by heterogeneous germline mutations in two of the Ext genes, EXT-1 and EXT-2, which encode ubiquitously expressed glycosyltransferases involved in the polymerization of heparan sulfate (HS) chains.
T4 512-812 Sentence denotes To examine whether the Ext mutation could affect HS structures and amounts in HME patients being heterozygous for the Ext genes, we collected blood from patients and healthy individuals, separated it into plasma and cellular fractions and then isolated glycosaminoglycans (GAGs) from those fractions.
T5 813-1186 Sentence denotes A newly established method consisting of a combination of selective ethanol precipitation of GAGs, digestion of GAGs recovered on the filter-cup by direct addition of heparitinase or chondroitinase reaction solution and subsequent high-performance liquid chromatography of the unsaturated disaccharide products enabled the analysis using the least amount of blood (200 µL).
T6 1187-1310 Sentence denotes We found that HS structures of HME patients were almost similar to those of controls in both plasma and cellular fractions.
T7 1311-1645 Sentence denotes However, interestingly, although both the amounts of HS and chondroitin sulfate (CS) varied depending on the different individuals, the amounts of HS in both the plasma and cellular fractions of HME patient samples were decreased and the ratios of HS to CS (HS/CS) of HME patient samples were almost half those of healthy individuals.
T8 1646-1792 Sentence denotes The results suggest that HME patients' blood exhibited reduced HS amounts and HS/CS ratios, which could be used as a diagnostic biomarker for HME.

GlyCosmos15-FMA

Id Subject Object Predicate Lexical cue db_id
T1 26-31 Body_part denotes blood FMA:9670
T2 221-230 Body_part denotes autosomal FMA:74406
T3 654-659 Body_part denotes blood FMA:9670
T4 717-723 Body_part denotes plasma FMA:62970
T5 1171-1176 Body_part denotes blood FMA:9670
T6 1280-1286 Body_part denotes plasma FMA:62970
T7 1473-1479 Body_part denotes plasma FMA:62970
T8 1685-1690 Body_part denotes blood FMA:9670

GlyCosmos15-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 26-31 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000315
T2 654-659 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000315
T3 1171-1176 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000315
T4 1685-1690 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000315

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 1510-1517 OrganismTaxon denotes patient 9606
T2 1583-1590 OrganismTaxon denotes patient 9606

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 26-31 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T2 654-659 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T3 717-723 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T4 1171-1176 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T5 1280-1286 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T6 1473-1479 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T7 1685-1690 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178